Vol. 32 No. 2 (2026)

This issue examines delayed metabolic imaging in a challenging oncological presentation. A case report describes dual-time-point FDG PET/CT detection of an occult liver metastasis in a patient with breast cancer showing neuroendocrine differentiation. The contribution connects delayed imaging findings with biopsy confirmation, illustrating the investigation of suspected recurrence when initial imaging does not explain rising tumor markers. The authors are affiliated with institutions in Egypt and the United Arab Emirates.